Trellus Health (LSE:TRLS) EPS (Basic) : £-0.03 (TTM As of Jun. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Trellus Health EPS (Basic)?

Trellus Health's basic earnings per share (Basic EPS) for the six months ended in Jun. 2024 was £-0.02. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Jun. 2024 was £-0.03.

Trellus Health's EPS (Diluted) for the six months ended in Jun. 2024 was £-0.02. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was £-0.03.

Trellus Health's EPS without NRI for the six months ended in Jun. 2024 was £-0.02. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Jun. 2024 was -0.03.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

Trellus Health EPS (Basic) Historical Data

The historical data trend for Trellus Health's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Trellus Health EPS (Basic) Chart

Trellus Health Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

EPS (Basic)

-0.04

-0.03

Trellus Health Semi-Annual Data
	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
EPS (Basic)	Get a 7-Day Free Trial			-0.02	-0.02	-0.02	-0.02	-0.02

Trellus Health EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Trellus Health's Basic EPS for the fiscal year that ended in Dec. 2023 is calculated as

Basic EPS (A: Dec. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-5.008	-	0)	/	161.508
	=	-0.03

Trellus Health's Basic EPS for the quarter that ended in Jun. 2024 is calculated as

Basic EPS (Q: Jun. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-3.058	-	0)	/	161.508
	=	-0.02

EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was £-0.03

Trellus Health (LSE:TRLS) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Trellus Health EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Trellus Health's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Trellus Health Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Trellus Health PLC (LSE:TRLS) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

N/A

Address

19 Stanwell Road, Avon House, Penarth, Cardiff, GBR, CF64 2EZ

Website

https://www.trellushealth.com

Trellus Health PLC is commercializing the provision of digital chronic condition management solutions for employers and health plans that utilize the scientifically validated GRITT resilience-based methodology and a proprietary HIPAA-compliant technology platform called TrellusElevate to coordinate and deliver personalized care. The company is initially focused on Inflammatory Bowel Diseases, which include the chronic incurable conditions of Crohn's Disease and ulcerative colitis but considers its approach to have potential utility and demand across many chronic conditions.

Trellus Health Headlines

No Headlines